Stock Earnings

Question 1

What are Canntab Therapeutics Limited's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), TC Energy Corp has a total asset of $118,751, Net profit of $3,400

Question 2

What are the key financial ratios for CTABF?

Accepted Answer

TC Energy Corp's Current ratio is 1.29, has a Net margin is 22.31, sales per share of $14.65.

Question 3

How is Canntab Therapeutics Limited's revenue broken down by segment or geography?

Accepted Answer

Currently TC Energy Corp data is not available.

Question 4

Is Canntab Therapeutics Limited profitable?

Accepted Answer

yes, according to the latest financial statements, TC Energy Corp has a net profit of $3,400

Question 5

Does Canntab Therapeutics Limited have any liabilities?

Accepted Answer

yes, TC Energy Corp has liability of 91,456

Question 6

How many outstanding shares for Canntab Therapeutics Limited?

Accepted Answer

TC Energy Corp has a total outstanding shares of 1,040.83

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	15,239	15,239	13,771	13,267	14,977	13,387
Revenue Growth (YoY)	11%	11%	4%	-11%	12%	3%
Cost of Revenue	4,619	4,619	4,413	4,073	4,932	4,098
Gross Profit	10,620	10,620	9,358	9,194	10,045	9,289
Selling, General & Admin	881	881	820	781	848	774
Research & Development	--	--	--	--	--	--
Operating Expenses	3,858	3,858	3,572	3,307	3,966	3,383
Other Non Operating Income (Expenses)	453	453	1,002	872	369	267
Pretax Income	5,444	5,444	5,906	3,298	1,374	2,166
Income Tax Expense	1,138	1,138	922	842	589	120
Net Income	3,400	3,400	4,594	2,829	641	1,815
Net Income Growth	-26%	-26%	62%	341%	-65%	-59%
Shares Outstanding (Diluted)	1,040	1,040	1,038	1,030	996	974
Shares Change (YoY)	0%	0%	1%	3%	2%	4%
EPS (Diluted)	3.26	3.26	4.42	2.74	0.64	1.86
EPS Growth	-26%	-26%	61%	328%	-66%	-61%
Free Cash Flow	2,060	2,060	1,338	-881	-352	966
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	69.68%	69.68%	67.95%	69.29%	67.06%	69.38%
Operating Margin	44.37%	44.37%	42.01%	44.37%	40.58%	44.11%
Profit Margin	22.31%	22.31%	33.35%	21.32%	4.27%	13.55%
Free Cash Flow Margin	13.51%	13.51%	9.71%	-6.64%	-2.35%	7.21%
EBITDA	9,531	9,531	8,574	8,665	8,663	8,428
EBITDA Margin	62.54%	62.54%	62.26%	65.31%	57.84%	62.95%
D&A For EBITDA	2,769	2,769	2,788	2,778	2,584	2,522
EBIT	6,762	6,762	5,786	5,887	6,079	5,906
EBIT Margin	44.37%	44.37%	42.01%	44.37%	40.58%	44.11%
Effective Tax Rate	20.9%	20.9%	15.61%	25.53%	42.86%	5.54%

Canntab Therapeutics Limited (CTABF) Financial